- Salary
- $290k – $320k
- Location
- Waltham, MA
- Workplace
- Onsite
- Type
- Full-time
- Department
- Openings
- Seniority
- Director
- Experience
- 12+ years
- Education
- PhD
- Source
- Lever
Description
Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies as single agents and as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X.
We are seeking an experienced corporate development leader to build and maintain a comprehensive view of the solid tumor oncology landscape, translate scientific and competitive intelligence into clear portfolio priorities, and identify external opportunities that can strengthen Crescent’s pipeline. You will partner cross-functionally with Research, Clinical Development, Business Development, and Executive leadership to evaluate assets, inform strategic decision-making, and prepare decision-oriented recommendations for the executive team and Board.
Benefits
Opportunity to join a mission-driven team where you'll contribute to impactful work, take on varied responsibilities, and grow quickly in a dynamic environmentCompetitive compensation, including base salary, performance bonus, and equity100% employer-paid benefits packageFlexible PTO.Two, one-week company-wide shutdowns each yearA commitment to your professional development, with access to resources, mentorship, and growth opportunities
